Products / Onchology y Oncohematology

Idarrux

Axitinib 5 mg

Axitinib is indicated for the treatment of adult patients with advanced renal cell cancer after failure of a previous treatment with sunitinib or cytokine.

Therapeutic Action

Antineoplastic

Presentations

60 coated tablets

This pharmaceutical product is gluten free. Suitable for celiacs.
Idarrux Axitinib 5 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use